SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-036955
Filing Date
2022-06-15
Accepted
2022-06-15 16:31:15
Documents
1
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7645
  Complete submission text file 0001209191-22-036955.txt   8987
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 CORTLAND STREET, 16TH FLOOR NEW YORK NY 10007
Business Address
Murdock Hunter R. (Reporting) CIK: 0001934008 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37635 | Film No.: 221018135